Search research articles
Contact Us
Filters
Showing results (371-380 of 669) with videos related to
Page
of 67
Sort By:
International Journal of Biological Sciences
|
July 30, 2021
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance
Silpa Narayanan, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Oncology Reports
|
March 26, 2013
Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
Wen Deng, Chun-Ling Dai, Jun-Jiang Chen, et al.
Frontiers in Pharmacology
|
December 13, 2023
Protective effects of Salvianic acid A against multiple-organ ischemia-reperfusion injury: a review
Shiyu Yang, Heming Chen, Wei Su, et al.
Signal Transduction and Targeted Therapy
|
March 11, 2023
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 4, 2021
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan-Chao Zhao, et al.
Frontiers in Oncology
|
October 5, 2020
Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
Xiaozhong Liao, Lanting Tao, Wei Guo, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: <i>In vitro</i> and <i>in vivo</i> study
Zhuo-Xun Wu, Qiu-Xu Teng, Yuqi Yang, et al.
European Journal of Medicinal Chemistry
|
February 5, 2022
Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin
Junkai Liu, Shaowen Xie, Xiao Shao, et al.
Frontiers in Pharmacology
|
January 29, 2019
Y<sub>6</sub>, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
Rui-Qiang Zhao, Yan Wen, Pranav Gupta, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
Silpa Narayanan, Nehaben A Gujarati, Jing-Quan Wang, et al.
Page
of 67
Search research articles
Search
Showing results (371-380 of 669) with videos related to
Sort By:
Page
of 67
International Journal of Biological Sciences
|
July 30, 2021
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance
Silpa Narayanan, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Oncology Reports
|
March 26, 2013
Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
Wen Deng, Chun-Ling Dai, Jun-Jiang Chen, et al.
Frontiers in Pharmacology
|
December 13, 2023
Protective effects of Salvianic acid A against multiple-organ ischemia-reperfusion injury: a review
Shiyu Yang, Heming Chen, Wei Su, et al.
Signal Transduction and Targeted Therapy
|
March 11, 2023
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 4, 2021
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan-Chao Zhao, et al.
Frontiers in Oncology
|
October 5, 2020
Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
Xiaozhong Liao, Lanting Tao, Wei Guo, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: <i>In vitro</i> and <i>in vivo</i> study
Zhuo-Xun Wu, Qiu-Xu Teng, Yuqi Yang, et al.
European Journal of Medicinal Chemistry
|
February 5, 2022
Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin
Junkai Liu, Shaowen Xie, Xiao Shao, et al.
Frontiers in Pharmacology
|
January 29, 2019
Y<sub>6</sub>, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
Rui-Qiang Zhao, Yan Wen, Pranav Gupta, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
Silpa Narayanan, Nehaben A Gujarati, Jing-Quan Wang, et al.
Page
of 67